Banner of CND: United Nations Commission on Narcotic Drugs, policymaking body of the United Nations system with prime responsibility for drug-related matters

WHO scheduling recommendations on cannabis and cannabis-related substances

Following the 41st meeting of the WHO Expert Committee on Drug Dependence (ECDD), WHO recommended in 2019, the rescheduling of cannabis and several cannabis-related substances. The Commission on Narcotic Drugs decided during its 62nd session in March 2019 to postpone the voting on the recommendations to provide Member States with more time. 

During the 4th and 5th Intersessional Meeting of the Commission on 24 June 2019 and 23 September, Member States were given the opportunity to address questions to WHO. The International Narcotics Control Board (INCB) and UNODC were also present to provide answers within their respective mandates.

During its 63rd session, the Commission decided to continue considerations of the recommendations and to vote during the 63rd reconvened session in December 2020. 

Member States conducted informal closed topical meetings on the recommendations. The first topical meeting took place on 24 and 25 June 2020 and focused on recommendations 5.4 and 5.5. The second topical meeting was organized on recommendations 5.2, 5.3 and 5.6 on 24 and 25 August 2020 and the third topical meeting on recommendation 5.1 on 6 7 October 2020.

The topical meetings were followed by an intersessional meeting on 8 October 2020 and was open to all stakeholders. Further information, including statements by Member States and non-governmental organizations, have been posted on the website of the 2nd Intersessional Meeting